Status: Recruiting
Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab
This is a non-interventional cohort study evaluating non-relapse mortality and toxicities in patients with CTCL or ATLL treated with mogamulizumab pre- or post- alloHCT for patients transplanted beginning January 1, 2012 until accrual is complete.
Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Kyowa Kirin, Inc.Updated: Jul 24, 2024Locations: 1Duration: 2 Years
Eligibility criteria
Patients registered to the Center for International Blood and Marrow Transplant... [+2]